Skip to main content
OpenTrials
Completed

NCT Number: NCT06047730

Clinical Effect Evaluation of Laparoscopic Surgery for Ovarian Benign Tumors by Different Approaches

Main purpose: To compare the intraoperative and postoperative recovery of laparoscopic surgery for ovarian benign tumors through different approaches; Secondary objective: Will vNOTES increase the risk of cesarean section during pregnancy and affect the quality of sexual life after surgery.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Preoperative consideration was for benign ovarian tumors requiring surgical treatment.

Exclusion criteria

  • (1) Ovarian malignant tumor or borderline tumor was considered before surgery or proved during surgery. (2) Severe endometriosis, previous severe pelvic inflammation, peritonitis, and other serious pelvic adhesions are considered. (3) Pregnancy status. (4) Postoperative follow-up is not convenient and lost visitors.

Treatment and study plan

operation ways

Procedure

nothing

Primary outcomes

  1. peroperative bleeding

    Time frame: during the operation time

    peroperative bleeding

Secondary outcomes

  1. postoperative exhaust time

    Time frame: within 3 days after operation

    postoperative exhaust time

Sponsors and collaborators

Lead sponsor

Yingchun Ma

Other

Registry information

Important dates

Study start
2017
Primary completion
2022
Study completion
2023
First posted
Sep 21, 2023
Registry last updated
Sep 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.